Drugs / G-CSF
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT05840640 | Oct 2017 → Feb 2021 | alcoholic hepatitis | Post Graduate Institute of Medical Education and Research, Chandigarh | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | G-CSF | “standard medical therapy plus G-CSF- 5μg/Kg s.c every 12 hours for 5 consecutive days” NCT05840640 ↗ |
| Modality | Protein / enzyme biologic | “G-CSF is a cytokine capable to regulate a number of functions in neutrophils.” NCT05840640 ↗ |
| Route | Subcutaneous | “G-CSF- 5μg/Kg s.c every 12 hours for 5 consecutive days” NCT05840640 ↗ |